266 results
8-K
TCRT
Alaunos Therapeutics, Inc.
10 Oct 24
Termination of a Material Definitive Agreement
8:30am
Statements
This Current Report on Form 8-K contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995
8-K
deekb9ox b63ei
15 Nov 23
Departure of Directors or Certain Officers
7:30am
8-K
EX-99.1
jmebvniswfi5
14 Nov 23
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
12:00am
8-K
EX-99.1
gyx9ekwavde
14 Aug 23
Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim
4:16pm
8-K
EX-99.1
amwnahl mgzaq
10 May 23
Alaunos Therapeutics Reports First Quarter 2023 Financial Results
7:09am
8-K
EX-99.1
4fo437xh9utr
30 Mar 23
Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of Directors
7:41am
8-K
EX-1.1
jh7ahx4p4ypr6ahmbslx
30 Nov 22
Alaunos Therapeutics Announces Proposed Public Offering of Common Stock
5:10pm